HLB바이오스텝
6,010KRWMarket close of 10/21 (Wed)
Up +0.33%+20KRWMarket close of 10/21 (Wed)
Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/22 (Thu)5,760KRWDown -4.16%
Preliminary · just after the close · replaced by official KRX data tomorrow morning
- Open
- 6,000
- High
- 6,280
- Low
- 5,910
- Day range
- Day range low 5,910 high 6,280, open 6,000, close 6,010, previous close 5,990
- Volume
- 47×10K shares
- 2.8B KRW 0.20× the 20-session average
Market close of 10/21 (Wed)
Something to check
1 to check: operating loss
Free · no sign-inSource from 2021-05-17
Points to check
- Earningsto check-8.7B KRWOperating income over the last four quarters -8.7B KRW (loss)
- Daily movenot verifiedOnly 15 daily bars to compare, so not verified
- Trading valuenot verifiedNot enough 20-session trading value data, so not verified
The other 3
- Recent filingsnot verified
- Foreign & institutionalnot verified
- Data date10/21 (Wed)Market close
See the full check report
Quarterly results · Q1 2026
- Revenue13.5B KRW
- vs. year ago
- -0.7%
- vs. prior quarter
- -28.0%
- Operating income-2.6B KRW
- vs. year ago
- Still a loss
- vs. prior quarter
- Still a loss
- Operating margin-19.4%
- vs. year ago
- -0.6 pp
- vs. prior quarter
- -7.5 pp
Quarterly operating income trend
As of the latest official close · 2026-10-21Valuation filing date · 2026-05-15Same sector · 바이오 R&D
Up +3.03%· 33 of 64 stocks up, preferred shares excluded · trading value 215.2B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 알테오젠 | Close over the last 20 sessions -5.5% | Up +3.90% | 60.7B KRW |
| 올릭스 | Close over the last 20 sessions -6.4% | Up +9.53% | 26.1B KRW |
| 디앤디파마텍 | Close over the last 20 sessions -6.0% | Up +6.65% | 22.0B KRW |
| 리가켐바이오 | Close over the last 20 sessions -14.3% | Up +2.00% | 12.9B KRW |
| 프로티나 | Close over the last 20 sessions +35.7% | Up +7.23% | 11.0B KRW |
Schedule
- Next data 10/23 (Fri) after 08:50
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 85% of trading value, about 92% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.